ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,295.30
1.00%
Dow Jones
38,852.27
0.46%
Gold vs US Dollar
2,313.75
-0.51%
Brent Oil
82.93
-0.65%
Bitcoin
64,128.59
1.52%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Century Therapeutics Inc (IPSC)

  7. Century Therapeutics Inc (IPSC) News

Century Therapeutics (IPSC)

Century Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPSC
DateTimeSourceHeadlineSymbolCompany
06/05/202421:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
23/04/202412:00GlobeNewswire Inc.Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:IPSCCentury Therapeutics Inc
11/04/202412:00GlobeNewswire Inc.Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade TherapeuticsNASDAQ:IPSCCentury Therapeutics Inc
08/04/202421:05GlobeNewswire Inc.Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
25/03/202411:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:IPSCCentury Therapeutics Inc
19/03/202411:00GlobeNewswire Inc.Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:IPSCCentury Therapeutics Inc
14/03/202411:30GlobeNewswire Inc.Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
08/03/202423:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/03/202421:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/03/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/03/202423:03GlobeNewswire Inc.Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
21/02/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
21/02/202418:04Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IPSCCentury Therapeutics Inc
16/02/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/02/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/02/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/02/202421:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/02/202420:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
01/02/202412:00GlobeNewswire Inc.Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IPSCCentury Therapeutics Inc
19/01/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
11/12/202315:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/12/202317:00GlobeNewswire Inc.Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ EditsNASDAQ:IPSCCentury Therapeutics Inc
06/12/202321:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/12/202321:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/12/202312:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
06/12/202312:30GlobeNewswire Inc.Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
06/12/202312:30GlobeNewswire Inc.Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
21/11/202312:00GlobeNewswire Inc.Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:IPSCCentury Therapeutics Inc
09/11/202312:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/11/202312:01GlobeNewswire Inc.Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IPSC

Your Recent History

LSE
AAZ
Anglo Asian Mining
LSE
PXC
Phoenix Copper
LSE
AGL
Angle
LSE
FDEV
Frontier Developments
LSE
KEFI
Kefi Gold And Copper
LSE
TERN
Tern
LSE
RR.
Rolls-royce
LSE
SCE
Surface Transforms
LSE
POS
Plexus
LSE
GCM
Gcm Resources
LSE
HUM
Hummingbird Resources
LSE
BIRD
Blackbird
LSE
TLY
Totally
LSE
CHLL
Chill Brands
LSE
NEXN
Nexxen
LSE
SYME
Supply@me Capital
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved